Latest article
Novo Nordisk presents trial outcomes of Xultophy for sort 2 diabetes
Novo Nordisk said Monday that its type 2 diabetes treatment Xultophy showed superior efficacy in reducing hemoglobin A1c (HbA1c) levels, weight change and lower...
Overtreatment linked to poor outcomes for older adults with diabetes
medwireNews: Researchers note that older adults with diabetes are often treated with...